- Recent Funding
- Investors
- Mass General Brigham Ventures
Mass General Brigham Ventures portfolio
Mass General Brigham Ventures has 6 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
It is a corporate venture investor based in Boston, US, founded in 2020. It led 1 of the 11 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. By category, its portfolio leans toward Health and bio (6) and Manufacturing and industrial (1). It has co-invested with Pontifax, Samsara Biocapital and RA Capital Management, most often Pontifax (5 rounds).
About Mass General Brigham Ventures
What Mass General Brigham Ventures invests in
- Health and bio · 6 · 100%
- Manufacturing and industrial · 1 · 17%
- Education · 1 · 17%
- Logistics and mobility · 1 · 17%
- Consumer and social · 1 · 17%
Mass General Brigham Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $60M | Global Brain Corporation, 4BIO Capital (lead), Eli Lilly +5 | ||
| Series B+ · $118M | Novo Holdings, Adage Capital Management, Janus Henderson Investors +5 | ||
| Series B+ · $18M | Storm Ventures, Memorial Hermann Health System, UPMC Enterprises (lead) +6 | ||
| Series B+ · $200M | Redmile Group, NEA (lead), Samsara Biocapital +5 | ||
| Series A · $57M | Novo Holdings, Janus Henderson Investors, Catalio +1 | ||
| Series B+ · $155M | Redmile Group (lead), Eurofarma, Samsara Biocapital +6 | ||
| Series A · $105M | Novartis Venture Fund (lead), Ono Venture Investment, Bristol-Myers Squibb +6 | ||
| Series B+ · $140M | Intermediate Capital Group (lead), Pontifax, OrbiMed +6 |
How Mass General Brigham Ventures invests
Mass General Brigham Ventures portfolio companies
OOyster Therapeutics$60MSeries A · Nov 2026
CClaris Bio$118MSeries B+ · Jul 2026
CCarta Healthcare$18MSeries B+ · Jun 2025
AAbcuro$200MSeries B+ · Feb 2025
MMediar Therapeutics$105MSeries A · Mar 2023
AAmolyt Pharma$140MSeries B+ · Jan 2023
| Company | Round with Mass General Brigham Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $60M | $60M | Nov 10, 2026 Series A |
Health and bio |
Series B+ · $118M | $175M | Jul 28, 2026 Series B+ |
Health and bio |
Series B+ · $18M | $80M | Jun 7, 2025 Series B+ |
Health and bio |
Series B+ · $200M | $463M | Aug 18, 2026 Series B+ |
Health and bio |
Series A · $105M | $181M | Jan 7, 2026 Series B+ |
Health and bio |
Series B+ · $140M | $294M | Jan 6, 2023 Series B+ |
Most frequent co-investors
PPontifax5 shared rounds · last Feb 12, 2025
SSamsara Biocapital4 shared rounds · last Jul 28, 2026
RRA Capital Management4 shared rounds · last Feb 12, 2025
SSofinnova Partners3 shared rounds · last Jul 28, 2026
SSanofi Ventures3 shared rounds · last Feb 12, 2025
MMission BioCapital2 shared rounds · last Nov 10, 2026
NNovo Holdings2 shared rounds · last Jul 28, 2026
JJanus Henderson Investors2 shared rounds · last Jul 28, 2026
CCatalio2 shared rounds · last Jul 28, 2026
SStorm Ventures2 shared rounds · last Jun 7, 2025
TThe CU Healthcare Innovation Fund2 shared rounds · last Jun 7, 2025
RRedmile Group2 shared rounds · last Feb 12, 2025
Similar investors
BBertelsmann India Investments8 companies · 4 deals in 12 mo
CCVS Health Ventures8 companies · 2 deals in 12 mo
RRegeneron Ventures10 companies · 5 deals in 12 mo
UUPMC Enterprises10 companies · 4 deals in 12 mo
KKB Investment11 companies · 3 deals in 12 mo
AAngelini Ventures14 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 11 rounds on Recent Funding that name Mass General Brigham Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Mass General Brigham Ventures, which is a subset of its real portfolio. API: /api/v1/investors/mass-general-brigham-ventures (get a free API key). More: the most active VC firms and new venture capital funds.